| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |